Cutaneous Langerhans cell sarcoma: A case report and review of the literature

International Journal of Hematology

Volumn 85, Issue 2, 2007, Pages 116-120

  Bohn, Olga L ^a,c   Ruiz Argüelles, Guillermo ^b   Navarro, Leticia ^a   Saldivar, Jesus ^a   Sanchez Sosa, Sergio ^a  

^a UPAEP University Hospital   (Mexico)

^b Clinica Ruiz   (Mexico)

^c Federal N Bldg ^*  (United States)

Author keywords

Dendritic cells; Langerhans cell sarcoma; Langerhans cells; Langerhans histiocytic disorders; Malignant Langerhans histiocytosis

Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; LANGERIN; PREDNISONE; PROTEIN S 100; T6 ANTIGEN; VINCRISTINE;

ADULT; ANTIBODY SCREENING; CASE REPORT; CELL PROLIFERATION; CERVICAL LYMPHADENOPATHY; COMBINATION CHEMOTHERAPY; CYTOLOGY; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LANGERHANS CELL SARCOMA; MALE; PROTEIN EXPRESSION; REVIEW; SCALP TUMOR; SKIN BIOPSY;

CYTOPLASMIC GRANULES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LANGERHANS CELLS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SKIN NEOPLASMS;

EID: 33847679759     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.NA0604     Document Type: Review

References (25)

1. Weiss LM, Grogan TM, Pileri SA, et al. Langerhans cell sarcoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:283.
2. Ben-Ezra J, Bailey A, Azumi N, et al. Malignant histiocytosis X: a distinct clinicopathologic entity. Cancer. 1991;68:1050-1060.
3. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
4. Kawase T, Hamazaki M, Ogura M, et al. CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol. 2005;81:323-329.
5. Wood C, Wood GS, Denaue DG, Oseroff A, Beckstead JH, Malin J. Malignant histiocytosis X: report of a rapidly fatal case in an elderly man. Cancer. 1984;54:347-352.
6. Itoh H, Miyaguni H, Kataoka H, et al. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman: report of a fatal case. J Cutan Pathol. 2001;28:371-378.
7. Tani M, Ishii N, Kumagai M, Ban M, Sasase A, Mishima Y. Malignant Langerhans cell tumour. Br J Dermatol. 1992;126:398-403.
8. Misery L, Godard W, Hamzeh H, et al. Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. J Am Acad Dermatol. 2003;49:527-529.
9. Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol. 2006;28:36-39.
10. Jülg BD, Weidner S, Mayr D. Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature. Virchows Arch. 2006;448:369-374.
11. Lee JS, Ko GH, Kim HC, Jan IS, Jeon KN, Lee JH. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci. 2006;21:577-580.
12. Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA. Malignant histiocytosis: a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer. 1990;66:530-536.
13. Mongkonsritragoon W, Li CY, Phyliky R. True malignant histiocytosis. Mayo Clin Proc. 1998;73:520-528.
14. Sato T, Terui T, Kogawa K, et al. A case of true malignant histiocytosis: identification of histiocytic origin with use of immunohistochemical and immunocytogenetic methods. Ann Hematol. 2002;81:285-288.
15. Pillay K, Solomon R, Daubenton J, Sinclair-Smith CC. Interdigitating dendritic cell sarcoma: a report of four paediatric cases and review of the literature. Histopathology. 2004;44:283-291.
16. Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol. 2004;7:607-614.
17. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer Suppl. 1994;23:S4-S10.
18. Valladeau J, Clair-Moninot V, Dezzuter-Dambuyant C, et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol. 2002;168:782-792.
19. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 1997;29:157-166.
20. Verdijk P, Dijkman R, Plasmeijer EI, et al. A lack of Birbeck granules in Langerhans cells is associated with a naturally occurring point mutation in the human langerin gene. J Invest Dermatol. 2005;124:714-717.
21. Grogg KL, Lae ME, Kurtin PJ, et al. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms. Am J Surg Pathol. 2004;28:988-998.
22. + NK lymphomas: clinicopathological features and prognosis. Br J Haematol. 1997;97:821-829.
23. +, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol. 2001;19:2179-2188.
24. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77.
25. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemic and blastic NK cell lymphoma/leukemia. Leuk Res. 1999;23:615-624.